Hypogammaglobulinaemia and thrombocytopenia associated with sulphasalazine therapy in rheumatoid arthritis.
作者信息
Farr M, Tunn E, Bacon P A, Smith D H
出版信息
Ann Rheum Dis. 1985 Oct;44(10):723-4. doi: 10.1136/ard.44.10.723-b.
Abstract
摘要
相似文献
1
Hypogammaglobulinaemia and thrombocytopenia associated with sulphasalazine therapy in rheumatoid arthritis.类风湿关节炎患者使用柳氮磺吡啶治疗相关的低丙种球蛋白血症和血小板减少症
Ann Rheum Dis. 1985 Oct;44(10):723-4. doi: 10.1136/ard.44.10.723-b.
2
Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquine.金硫葡萄糖、柳氮磺胺吡啶和羟氯喹所致的血小板减少症。
Ann Rheum Dis. 1990 Oct;49(10):798-800. doi: 10.1136/ard.49.10.798.
3
[Changes in the blood picture in sulfasalazine therapy of rheumatoid arthritis].[类风湿关节炎柳氮磺胺吡啶治疗中的血象变化]
Z Rheumatol. 1987 Mar-Apr;46(2):86-91.
4
Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis.
Br J Rheumatol. 1992 May;31(5):351-3. doi: 10.1093/rheumatology/31.5.351.
5
Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin.
Clin Rheumatol. 1998;17(4):349-52. doi: 10.1007/BF01451021.
6
Side effect profile of 200 patients with inflammatory arthritides treated with sulphasalazine.200例接受柳氮磺胺吡啶治疗的炎性关节炎患者的副作用情况
Drugs. 1986;32 Suppl 1:49-53. doi: 10.2165/00003495-198600321-00010.
7
Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis.柳氮磺胺吡啶诱发一名类风湿关节炎患者出现免疫性血小板减少症。
Clin Rheumatol. 2017 Feb;36(2):477-479. doi: 10.1007/s10067-016-3420-9. Epub 2016 Oct 24.
8
Macrocytosis and sulphasalazine treatment of rheumatoid arthritis.类风湿关节炎的大细胞症与柳氮磺胺吡啶治疗
Br J Rheumatol. 1987 Dec;26(6):472-3. doi: 10.1093/rheumatology/26.6.472.
9
Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.
Clin Rheumatol. 1991 Jun;10(2):178-80. doi: 10.1007/BF02207660.
10
Neutropenia in patients with rheumatoid arthritis, treated with sulphasalazine.类风湿关节炎患者使用柳氮磺胺吡啶治疗后的中性粒细胞减少症。
Br J Rheumatol. 1990 Oct;29(5):407-9. doi: 10.1093/rheumatology/29.5.407.
引用本文的文献
1
Genetics of IgA deficiency and common variable immunodeficiency.IgA缺乏症和常见变异型免疫缺陷的遗传学
Clin Rev Allergy Immunol. 2000 Oct;19(2):127-40. doi: 10.1385/CRIAI:19:2:127.
2
The clinical value of measuring immunoglobulins when assessing penicillamine therapy in rheumatoid arthritis.在评估类风湿关节炎患者青霉胺治疗效果时检测免疫球蛋白的临床价值。
Clin Rheumatol. 1988 Sep;7(3):347-53. doi: 10.1007/BF02239191.
3
Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquine.金硫葡萄糖、柳氮磺胺吡啶和羟氯喹所致的血小板减少症。
Ann Rheum Dis. 1990 Oct;49(10):798-800. doi: 10.1136/ard.49.10.798.
本文引用的文献
1
Hypogammaglobulinaemia associated with gold therapy.与金疗法相关的低丙种球蛋白血症
Ann Rheum Dis. 1984 Aug;43(4):581-2. doi: 10.1136/ard.43.4.581.
2
The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.柳氮磺胺吡啶治疗类风湿性关节炎的长期疗效及与青霉胺的对比研究。
Clin Rheumatol. 1984 Dec;3(4):473-81. doi: 10.1007/BF02031270.
3
Sulphasalazine: a 'new' antirheumatic drug.
Br J Rheumatol. 1984 Feb;23(1):26-34. doi: 10.1093/rheumatology/23.1.26.
4
Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis.柳氮磺胺吡啶可诱发类风湿关节炎患者出现选择性IgA缺乏。
Br Med J (Clin Res Ed). 1983 May 14;286(6377):1547-8. doi: 10.1136/bmj.286.6377.1547.
5
Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.柳氮磺胺吡啶（艾迪莎）治疗溃疡性结肠炎的不良反应。
South Med J. 1968 Apr;61(4):354-8. doi: 10.1097/00007611-196804000-00005.
6
Hypogammaglobulinaemia associated with gold therapy.与金疗法相关的低丙种球蛋白血症
Ann Rheum Dis. 1985 Mar;44(3):212. doi: 10.1136/ard.44.3.212-a.
7
Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.柳氮磺胺吡啶：一种用于长期控制类风湿性关节炎的安全、有效药物。与金硫代苹果酸钠的比较。
Ann Rheum Dis. 1985 Mar;44(3):194-8. doi: 10.1136/ard.44.3.194.
Zotero 插件